Evaluating only Healthymize’s profile at its peak — without knowing the outcome — the model ranked Regulation as the #1 likely cause. That’s exactly how it died.
Key Events Timeline
FOUNDING
Elad Madar founded Healthymize in Caesarea to detect respiratory conditions via voice AI analysis.
FDA de-novo pathway requirements for diagnostic device classification blocked commercial launch.
SHUTDOWN
Failed to close Series A; IP sold to undisclosed buyer and company dissolved.
Full Analysis
Free · no account needed
Documented cause
Healthymize, founded by Elad Madar in Caesarea, raised $5M to develop AI voice analysis tools detecting respiratory diseases including COPD and COVID-19 from speech patterns. The company struggled to navigate FDA regulatory pathways for its diagnostic claims and failed to secure reimbursement coding from US payers. After failing to close a Series A in 2021-2022, Healthymize shut down and sold its IP to an undisclosed buyer.
Lesson
“Diagnostic AI requires FDA clearance AND payer reimbursement codes — achieve both before Series A.”